Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01047735 · ClinicalTrials.gov registry record · NA

The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes

A NA study of Obesity and Type 2 Diabetes Mellitus, sponsored by University of Pittsburgh.

Active
Registry status
NA
Development phase
69
Enrollment target
1
Study location

NCT01047735: Active NA study of Obesity and Type 2 Diabetes Mellitus, sponsored by University of Pittsburgh.

NCT01047735 is a NA study of Obesity and Type 2 Diabetes Mellitus that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 69 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01047735, a NA study of Obesity and Type 2 Diabetes Mellitus, is active but no longer recruiting, sponsored by University of Pittsburgh.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
69 participants
Enrollment target
1
Study location

Study Summary

This research study is being performed to begin to determine the effectiveness of two dominant bariatric surgery procedures versus an intensive lifestyle intervention to induce weight loss in patients and promote improvements in Type 2 diabetes mellitus (T2DM) in moderately obese patients. T2DM is currently the 6th leading cause of mortality in the United States and is a major cause of kidney failure, blindness, amputations, heart attack, and other vascular and gastro-intestinal dysfunctions. Traditionally, treatments include intensive lifestyle modifications with or without glucose lowering agents. Neither treatment alone, or in combination, results in complete resolution of diabetes and its potential long-term complications. Bariatric surgery has been proven as an effective treatment to accomplish sustained and significant weight loss for those with severe obesity and has been shown to induce long-term remission of T2DM. However, despite enthusiasm for these potential treatment options, it is not clear whether diabetes is influenced by the type of surgery or by the amount of weight lost or if bariatric surgery is more effective than non-surgical weight loss induced by diet and physical activity in T2DM patients with moderate BMIs (30-40kg/m2; Class I and Class II obesity, or approximately 65-95 pounds overweight depending on your height). More well-controlled studies are needed to more completely inform health care decision making and clinical practice in this area. This research study aims to obtain preliminary information regarding the effectiveness of two major types of bariatric surgery, Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Adjustable Gastric Banding versus an intensive lifestyle intervention to induce weight loss with diet and increased physical activity.

Interventions

  • PROCEDURE Roux-en-Y Gastric Bypass Surgery
  • PROCEDURE Laparoscopic Adjustable Gastric Banding
  • BEHAVIORAL Lifestyle Weight Loss Intervention

Study Locations (1)

Pennsylvania

  • William F Gourash - Pittsburgh

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2009-09-01
Est. Completion 2028-07-01
Phase NA
University of Pittsburgh

1,238 total trials

What the registry record for NCT01047735 still lists

NCT01047735 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (92% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Roux-en-Y Gastric Bypass Surgery is the first listed.

NCT01047735 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01047735 about?

NCT01047735 is a clinical study titled "The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes". This research study is being performed to begin to determine the effectiveness of two dominant bariatric surgery procedures versus an intensive lifestyle intervention to induce weight loss in patients and promote improvements in Type 2 diabetes mellitus (T2DM) in moderately obese patients. T2DM is ...

What is the current status of trial NCT01047735?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 69 participants. The study started on 2009-09-01. Estimated completion is 2028-07-01.

What conditions does trial NCT01047735 study?

This clinical trial studies the following conditions: Obesity, Type 2 Diabetes Mellitus.

What interventions are being tested in trial NCT01047735?

The interventions under investigation include: Roux-en-Y Gastric Bypass Surgery (PROCEDURE), Laparoscopic Adjustable Gastric Banding (PROCEDURE), Lifestyle Weight Loss Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01047735?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01047735 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01047735's enrollment target sits among peer trials

69 606th of 1053 higher than 444 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04020575 · 69 participants · Phase 1

    Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

  • NCT04163614 · 69 participants · NA

    Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

  • NCT04164641 · 69 participants · NA

    Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration

  • NCT04493372 · 69 participants · NA

    Deciphering Preserved Autonomic Function After Spinal Cord Injury

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01047735, the US trial registry maintained by the National Library of Medicine. NCT01047735 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.